7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Another Deal for Healthways

by Zacks Equity Research

October 05, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Well-being enhancement company Healthways ( HWAY - Analyst Report ) recently entered into a partnership with not-for-profit healthcare company Regence binding through 2015. The three-year partnership will require Healthways to offer its SilverSneakers Fitness Program to more than 100,000 Regence Medicare Advantage PPO members in Oregon, Washington, Idaho and Utah.

The SilverSneakers Fitness Program is a well-regarded physical activity program to improve well-being of older citizens in the U.S. implying reduced costs associated with healthcare. It encourages positive changes in behavior by promoting a physical regimen. This will result in lower disease rates resulting in reduced medical expenditure for older adults.

The contract fee will garner incremental revenues for Healthways. Its second quarter revenues increased 0.4% year over year to $170.2 million, supported by the acknowledgement of performance-based fees.

The company inked 23 new, expanded or extended contracts in the most recent quarter. The count included nine fresh contracts, one expanded contract, two expanded and extended contracts and 11 extended contracts. The company also extended its SilverSneakers Fitness Program contract with WellPoint ( WLP - Analyst Report ) .

Earlier, Healthways revealed agreements to provide its SilverSneakers Fitness Program to Florida Blue, UCare and Humana ( HUM - Analyst Report ) .

The Healthways model encourages people to make favorable lifestyle changes that lead to enhanced well-being, reduced healthcare costs, improved performance and economic value. The company has invested in technology platforms that provide scalable support with large populations. It has tie-ups with a large proportion of U.S. health plans and counts many millions of lives in its customer base.

Healthways currently retains a long-term “Outperform” recommendation, supported by a short-term Zacks #2 Rank (Buy). The company is the leader in a strategically critical and rapidly evolving part of the health care services market. Its fitness program (SilverSneakers) for seniors is available at over 15,000 centers across the U.S. and is available to over nine million eligible enrollees through Medicare Supplement, Medicare Advantage plans and group retiree plans. Healthways competes with Express Scripts ( ESRX - Analyst Report ) among others.

Due to its unique scalable business model, Healthways shares present a long-term investment opportunity, although it faces certain challenges in the short term.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.